alendronate has been researched along with limestone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, NH; Bröll, J; Dequeker, J; Downs, RW; Favus, M; Liberman, UA; Minne, HW; Quan, H; Rodriguez-Portales, J; Weiss, SR | 1 |
| Bettica, P; Bevilacqua, M; Cucinotta, E; Masino, M; Norbiato, G; Vago, T | 1 |
| Braga de Castro Machado, A; Eastell, R; Hannon, R | 1 |
| Kashyap, AS; Kashyap, S | 1 |
| Chan, YH; Griffith, J; Lau, EM; Woo, J | 1 |
| Jiang, Y; Li, M; Meng, X; Tian, J; Xia, W; Xing, X; Yu, W; Zhou, X | 1 |
| Arlot, M; Chavassieux, P; Meunier, PJ; Yates, AJ | 1 |
| Açikgöz, G; Erdem, CZ; Ozdolap, S; Sarikaya, S | 1 |
| El-Agroudy, AE; El-Husseini, AA; El-Sayed, M; Ghoneim, MA; Mohsen, T | 1 |
| Başdemir, G; Eyigör, S; Kirazli, Y; Memis, A | 1 |
| Eastell, R; Ingle, BM; Machado, AB; Pereda, CA | 1 |
| Bilezikian, JP; Black, DM; Ensrud, KE; Greenspan, SL; Hue, T; Lang, TF; McGowan, JA; Palermo, L; Rosen, CJ | 1 |
| Atkinson, SA; Barr, RD; Guo, CY; Webber, C; Wiernikowski, JT; Wright, M | 1 |
| Chow, SK; Fauzi, AR; Goh, EM; Halim, AG; Kong, NC; Rahimah, I; Soehardy, Z; Yeap, SS | 1 |
| Jayaraman, M; Karikumar, K; Modi, KD; Verma, A | 1 |
| Paz-Pacheco, E; Sandoval, MA | 1 |
| Ayyoub, S; Coyne, C | 1 |
| Da Silva Júnior, NG; da Silva Kataoka, MS; de Jesus Viana Pinheiro, J; de Melo Alves Júnior, S; de Mendonça, RP; Mitre, GP; Real, FH; Vianna, P | 1 |
| Liu, B; Liu, JP; Qin, MZ; Zhou, J | 1 |
| Bao, L; Chen, H; Feng, F; Jia, P; Tang, H; Wang, R; Yuan, J | 1 |
| Cai, M; Chen, Y; Li, Y; Min, W; Wang, C; Wang, J; Yan, L; Zhang, R; Zhu, H | 1 |
1 review(s) available for alendronate and limestone
| Article | Year |
|---|---|
A case of pregnancy and lactation-associated osteoporosis and a review of the literature.
Topics: Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium Carbonate; Drug Therapy, Combination; Female; Fractures, Compression; Humans; Lactation; Osteoporosis; Pregnancy; Pregnancy Complications; Quality of Life; Vitamin D | 2020 |
12 trial(s) available for alendronate and limestone
| Article | Year |
|---|---|
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Topics: Aged; Aged, 80 and over; Alendronate; Body Height; Bone Density; Calcium Carbonate; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Spinal Fractures; Spine | 1995 |
Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared.
Topics: Adult; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Carbonate; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Peptides; Time Factors | 1997 |
Monitoring alendronate therapy for osteoporosis.
Topics: Aged; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Calcium Carbonate; Collagen; Collagen Type I; Female; Humans; Middle Aged; Osteocalcin; Osteogenesis; Osteoporosis, Postmenopausal; Peptides | 1999 |
Alendronate prevents bone loss in Chinese women with osteoporosis.
Topics: Aged; Alendronate; Bone Density; Calcium Carbonate; China; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos | 2000 |
[Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Calcium Carbonate; Double-Blind Method; Female; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Treatment Outcome | 2002 |
The effects of alendronate on bone turnover and bone quality.
Topics: Alendronate; Bone and Bones; Bone Remodeling; Bone Resorption; Calcium Carbonate; Double-Blind Method; Female; Humans; Osteogenesis; Osteoporosis | 1999 |
A prospective randomized study for prevention of postrenal transplantation bone loss.
Topics: Adult; Alendronate; Bone Density; Calcitonin; Calcium Carbonate; Humans; Hydroxycholecalciferols; Kidney Transplantation; Male; Osteoporosis; Parathyroid Hormone; Prospective Studies; Single-Blind Method | 2005 |
Monitoring alendronate and estradiol therapy with quantitative ultrasound and bone mineral density.
Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium Carbonate; Double-Blind Method; Drug Implants; Estradiol; Female; Femur Neck; Finger Phalanges; Follow-Up Studies; Humans; Hysterectomy; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Radiography; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2005 |
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodeling; Calcium Carbonate; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Treatment Outcome; Vitamin D | 2005 |
Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Child; Child, Preschool; Collagen; Collagen Type I; Female; Humans; Lumbar Vertebrae; Lymphoma, Non-Hodgkin; Male; Osteocalcin; Parathyroid Hormone; Peptides; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Time Factors; Treatment Outcome; Vitamin D | 2005 |
A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Lupus Erythematosus, Systemic; Osteoporosis; Premenopause; Young Adult | 2008 |
Fall Prevention and Anti-Osteoporosis in Osteopenia Patients of 80 Years of Age and Older: A Randomized Controlled Study.
Topics: Accidental Falls; Aged, 80 and over; Alendronate; Biomarkers; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium Carbonate; Drug Therapy, Combination; Female; Gait; Hand Strength; Humans; Hydroxycholecalciferols; Male; Osteoporosis | 2020 |
8 other study(ies) available for alendronate and limestone
| Article | Year |
|---|---|
Hypoparathyroidism unmasked by alendronate.
Topics: Aged; Alendronate; Calcitriol; Calcium Carbonate; Calcium Channel Agonists; Female; Humans; Hypocalcemia; Hypoparathyroidism; Osteoporosis, Postmenopausal | 2000 |
Pregnancy-associated osteoporosis with vertebral fractures and scoliosis.
Topics: Absorptiometry, Photon; Adult; Alendronate; Back Pain; Bone Density; Calcium Carbonate; Exercise Therapy; Female; Femur; Humans; Lumbar Vertebrae; Maternal Age; Orthotic Devices; Osteoporosis; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Scoliosis; Spinal Fractures; Thoracic Vertebrae; Treatment Outcome | 2004 |
Erdheim-Chester disease: the effect of bisphosphonate treatment--a case report.
Topics: Alendronate; Calcium Carbonate; Diagnosis, Differential; Diphosphonates; Drug Therapy, Combination; Erdheim-Chester Disease; Female; Humans; Middle Aged; Vitamin D | 2005 |
Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.
Topics: Adolescent; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium Carbonate; Cholecalciferol; Diagnosis, Differential; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Fractures, Bone; Humans; Radiography; Treatment Outcome | 2011 |
Primary hyperparathyroidism with classic and severe skeletal involvement.
Topics: Adenoma; Alendronate; Calcitriol; Calcium Carbonate; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Hyperparathyroidism, Primary; Middle Aged; Osteoporosis; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Postoperative Care; Radiography; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2010 |
VISUAL VIGNETTE.
Topics: Alendronate; Bone Density Conservation Agents; Calcium Carbonate; Female; Femoral Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 2018 |
Central Giant Cell Granuloma Treated with Intralesional Corticosteroid Injections and Bisphosphonates: A Long-Term Follow-Up Case Study.
Topics: Adrenal Cortex Hormones; Alendronate; Anti-Inflammatory Agents; Bone Density Conservation Agents; Calcium Carbonate; Child; Diphosphonates; Female; Follow-Up Studies; Granuloma, Giant Cell; Humans; Injections, Intralesional; Maxillary Diseases; Time; Triamcinolone Acetonide | 2020 |
Investigating the Preventive Effects of 99Tc-Methylenediphosphonate on a Glucocorticoid-Induced Osteoporosis Rabbit Model.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Calcium Carbonate; Diphosphonates; Disease Models, Animal; Female; Glucocorticoids; Osteoporosis; Rabbits; Technetium | 2021 |